Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 02 Apr 2025

Clinical and molecular characteristics, therapeutic strategies, and prognosis of non-small cell lung cancer patients harboring primary and acquired BRAF mutations

in Thoracic Oncology

Xiangran Feng
Ran Zeng
Mengchen Lyu
Xiaoyan Chen
Ziwei Xu
Yue Hu
Zhiyao Bao
Xianwen Sun
Jingya Zhao
Ling Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1514653

173 views

Original Research

Accepted on 01 Apr 2025

Influence of age and gender on the diagnostic accuracy of pleural fluid carcinoembryonic antigen for malignant pleural effusion: a post hoc analysis

in Thoracic Oncology

Dan-Ni Yang
Jian-Xun Wen
Yan Niu
Ling Hai
Qian Yang
Su-Na Cha
Cheng Yan
Hong-Zhe Zhu
Tingwang Jiang
Li Yan

Frontiers in Oncology

doi 10.3389/fonc.2025.1549621

501 views

Original Research

Published on 01 Apr 2025

Analysis of screen-detected pulmonary nodules before and after the novel coronavirus epidemic: a multicenter retrospective cohort study

in Thoracic Oncology

Zemin He
Keting Liu
Ling Wu
Qiang Wei
Qingwei Shen

Frontiers in Oncology

doi 10.3389/fonc.2025.1534074

418 views

Original Research

Accepted on 31 Mar 2025

Real-World Analysis of the Efficacy and Safety of Lorlatinib in ALK-Positive Non-Small Cell Lung Cancer Patients in China

in Thoracic Oncology

Guangming Tian
Xinliang Zhao
Jian Fang
Jun Nie
Ling Dai
Weiheng Hu
Jie Zhang
Di Wu
Xiangjuan Ma
Xiaoling Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1577607

Original Research

Published on 31 Mar 2025

Survival benefit from abemaciclib in non–small cell lung cancer by Kirsten rat sarcoma–mutation gene expression subtype: retrospective analysis from the JUNIPER Trial

in Thoracic Oncology

Jiangang Liu
Hong Wang
Amit Aggarwal
Maria Jesus Ortiz-Ruiz
Elisabet Zapatero-Solana
Maria Jose Lallena
Sandra Peregrina
Gloria Martinez del Hoyo
Susana Velasco
Philip J. Ebert

Frontiers in Oncology

doi 10.3389/fonc.2025.1461530

253 views

Case Report

Accepted on 28 Mar 2025

A Case of First-Line Treatment for Rare ROS1 Fusion Mutation Lung Adenocarcinoma with Entrectinib

in Thoracic Oncology

Yifan Yang
Qing Yi
Wei Yang
Yongzhong Luo
Lemeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1566687

Case Report

Accepted on 28 Mar 2025

Case Report: Severe brigatinib-induced pneumonitis in a patient with EML4-ALK+ metastatic non-small cell lung adenocarcinoma

in Thoracic Oncology

Khyati Somayaji Dasika
Megan Melody
Jyoti D. Patel

Frontiers in Oncology

doi 10.3389/fonc.2025.1572425

Case Report

Accepted on 28 Mar 2025

Advanced Lung Adenocarcinoma Harboring Uncommon EGFR 19 Del and T790M/trans-C797S Mutations after Resistance: A Case Report and Literature Review

in Thoracic Oncology

Yuting Xiao
Dunqiang Ren
BI Huanhuan
Yinxue Zhou
Yanmei Shao
Weizhong Han
Na Na
HONGMEI WANG

Frontiers in Oncology

doi 10.3389/fonc.2025.1525885

Case Report

Published on 28 Mar 2025

Lung cancer with supraclavicular myxoinflammatory fibroblastic sarcoma is easily misdiagnosed as lymph node metastasis: a case report

in Thoracic Oncology

Qian Yang
Jie Chen
Xiao Feng
Shue Zeng

Frontiers in Oncology

doi 10.3389/fonc.2025.1561193

199 views

Case Report

Published on 28 Mar 2025

Case Report: Intestinal metastasis from ALK-rearranged pulmonary pleomorphic carcinomas mimicking inflammatory myofibroblastic tumors

in Thoracic Oncology

Changle Shi
Yan Qiu
Kang He
Yuli Li
Qingsong Wan
Jin Yao
Hongying Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1496752

170 views

Case Report

Published on 28 Mar 2025

Unmasking the mimic: lipoid pneumonia imitating primary lung cancer - a case report series of a diagnostic challenge

in Thoracic Oncology

Shehab Mohamed
Luca Bertolaccini
Mariano Lombardi
Clementina Di Tonno
Angela Sabalic
Monica Casiraghi
Lorenzo Spaggiari

Frontiers in Oncology

doi 10.3389/fonc.2025.1538418

165 views

Correction

Published on 26 Mar 2025

Corrigendum: Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients – a nationwide and longitudinal study

in Thoracic Oncology

Johanne Elise Nyen
Anja Ødegård Booth
Øyvind Husby
Christoffer Bugge
Ingrid Engebretsen
Francisco Oteiza
Åslaug Helland
Lars Fjellbirkeland
Odd Terje Brustugun
Bjørn Henning Grønberg

Frontiers in Oncology

doi 10.3389/fonc.2025.1595028

203 views

Review

Accepted on 25 Mar 2025

Transcatheter Arterial Chemoembolization for Lung Malignant Tumors

in Thoracic Oncology

Fen-Xiang Zhang
Yu-Jin LIU

Frontiers in Oncology

doi 10.3389/fonc.2025.1551644

Original Research

Accepted on 24 Mar 2025

Analysis of clinical factors and inflammatory cytokines in patients with lung cancer and sarcopenia: A prospective single-center cohort study

in Thoracic Oncology

Yalan Liu
Hui Zhang
Peng Chen
Xinfu Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1564399

Original Research

Accepted on 24 Mar 2025

Enhancing Survival Predictions in Lung Cancer with Cystic Airspaces: A Multimodal Approach Combining Clinical and Radiomic Features

in Thoracic Oncology

Liang Yin
jing wang
pingyou fu
lu xing
yuan liu
zongchang li
jie gan

Frontiers in Oncology

doi 10.3389/fonc.2025.1524212

Systematic Review

Published on 24 Mar 2025

Olaparib monotherapy or combination therapy in lung cancer: an updated systematic review and meta- analysis

in Thoracic Oncology

Sajjad Hajihosseini
Ehsan Emami
Seyed Amirali Zakavi
Parnia Jochin
Mehregan Shahrokhi
Sahar Khoshravesh
Mitra Goli
Mohaddeseh Belbasi
Gisou Erabi
Niloofar Deravi

Frontiers in Oncology

doi 10.3389/fonc.2025.1505889

361 views